SELECTION :
- Etonitazepyne in counterfeit oxycodone tablets - a fatal case report. Midttun L., Skarshaug L.J., Krabseth H.-M., Gundersen P.O.M., Hansen M., Brekke M.B., et al., art. bkaf065.
- Artificial intelligence in new psychoactive substances analysis: state-of-art and future perspectives. Di Giorgi A., Pichini S., Busardò F.P., Basile G., art. bkaf071.
- The acute and chronic pharmacokinetics and pharmacodynamics of oral cannabidiol with and without low doses of delta-9-tetrahydrocannabinol. Wolinsky D., Zamarripa C.A., Spindle T.R., Klausner M., Cone E.J., Winecker R.E., et al., art. bkaf075.
- Xylazine and major urinary metabolites detected in patients positive for fentanyl and xylazine. Lin Y., Crews B.O., art. bkaf078.
- The detection of delta-9-tetrahydrocannabinol, delta-8-tetrahydrocannabinol, delta-10-tetrahydrocannabinol, and cannabidiol in hair specimens. Racines A., Jones J., Lea K., Coy D., art. bkaf079.
- Expanding fentanyl analog testing to include brain specimens: method validation and homogenate stability assessment. Behnke G., Skillman B., Palmquist-Orlando K., Arndt C., Gray T.R., art. bkaf082.
- Recommendations for toxicological investigation of drug-impaired driving and motor vehicle fatalities - 2025 update. D'Orazio A.L., Mohr A.L.A., Chan-Hosokawa A., Harper C., Huestis M.A., Kerrigan S., et al., art. bkaf085.
- Adsorption of tetrahydrocannabinol, metabolites, and related cannabinoids during storage of plasma samples in gel separation tubes. Abdul I.A., Pon D., Giancola C., Woodall K., art. bkag001.